Results 181 to 190 of about 715,867 (372)

Spontaneous Bacterial Peritonitis Is Associated With High Mortality, Which Interacts With Antibiotic Prophylaxis in a National Cirrhosis Cohort

Alimentary Pharmacology &Therapeutics, EarlyView.
In a national cohort of newly decompensated Veterans with cirrhosis, SBP and recurrences are linked with higher death and need for liver transplant. SBP prophylaxis, whether primary or secondary, worsens resistance and interacts with mortality but not liver transplant.
Scott Silvey, Nilang Patel, Jacqueline G. O'Leary, Timothy Morgan, John D. Markley, Sofia S. Jakab, Heather Patton, Shari Rogal, Jasmohan S. Bajaj   +8 more
wiley   +1 more source

Barriers to Medical Care Are Frequently Reported by Patients With Cirrhosis

Alimentary Pharmacology &Therapeutics, EarlyView.
In a telephone‐based survey study among > 1000 patients with cirrhosis, the most frequent barriers to care included time to travel to clinic, long wait times for appointments, and difficulty scheduling visits. Several barriers to care significantly differed by study site but were generally consistent across racial and ethnic subgroups.
William Chai, Nicole E. Rich, Yan Liu, Juana Campos, Lisa Quirk, Jennifer R. Kramer, Jahna Anyanwu, Amanda Gibbons, Aaron Loewy, Dalal Youssef, Riya Malhorta, Hadley McGhee, Meena Tadros, Fasiha Kanwal, Amit G. Singal   +14 more
wiley   +1 more source

Shunt occlusion prior to lenvatinib administration prevents hepatic encephalopathy and hyperammonemia

, 2020
Ai Kuwahara, Ryu Sasaki, Masanori Fukushima, Masafumi Haraguchi, Satoshi Miuma, Hisamitsu Miyaaki, Kazuhiko Nakao   +6 more
openalex   +1 more source

Abstract No. 627 Proton pump inhibitors are associated with increased risk of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt creation [PDF]

, 2018
Deborah Lewis, Paul V. Suhocki, Matthew J. Hall, T.P. Smith, Cho Hee Kim, James Ronald   +5 more
openalex   +1 more source

ASSESSMENT OF THE DYNAMICS OF HEPATIC ENCEPHALOPATHY IN PATIENTS WITH CIRRHOSIS BEFORE AND AFTER IN-HOSPITAL TREATMENT

, 2022
Bekmuradova Makhsuda Salkhidinovna
openalex   +1 more source

The neurogliovascular unit in hepatic encephalopathy

JHEP Reports, 2021
Wouter Claeys, Lien Van Hoecke, S. Lefere, A. Geerts, X. Verhelst, H. Van Vlierberghe, H. Degroote, L. Devisscher, R. Vandenbroucke, C. Van Steenkiste   +9 more
semanticscholar   +1 more source

Impact of Evolving Evidence on Pharmacological Therapy for Alcohol‐Associated Hepatitis in Alberta: A Population‐Based Study of Practice Trends and MELD‐Stratified Effectiveness of Corticosteroids

Alimentary Pharmacology &Therapeutics, EarlyView.
In this population‐based study in Alberta, Canada, evidence from RCTs led to a rapid reversal in pentoxifylline use, prior to formal guideline updates. Real‐world data support a modest short‐term benefit of CS and illustrate the potential of target trial emulation to assess treatment effectiveness in specific groups of patients. ABSTRACT Background and
Abdel‐Aziz Shaheen, Meng Wang, Bryce Tkachuk, Juan G. Abraldes   +3 more
wiley   +1 more source

Amino Acid Imbalance Is an Independent Factor for Mortality in Patients With Liver Cirrhosis

Alimentary Pharmacology &Therapeutics, EarlyView.
Amino acid imbalance, reflected by a low branched‐chain amino acids (BCAA)‐to‐tyrosine ratio (BTR), independently predicts mortality in patients with cirrhosis. Both decreased serum BCAA and increased tyrosine levels are significant and independent prognostic markers.
Yuki Utakata, Takao Miwa, Shinji Unome, Naoya Masuda, Mikita Oi, Masashi Aiba, Kenji Imai, Koji Takai, Makoto Shiraki, Naoki Katsumura, Masahito Shimizu   +10 more
wiley   +1 more source

Hepatic Encephalopathy [PDF]

Journal of Clinical and Experimental Hepatology, 2015
openaire   +2 more sources

Statin Therapy Independently Reduces Mortality and Liver Complications in Patients With Cirrhosis: An Updated Systematic Review and Meta‐Analysis

Alimentary Pharmacology &Therapeutics, EarlyView.
Statin therapy in cirrhosis may confer a survival benefit while reducing the risk of hepatic decompensation and hepatocellular carcinoma. ABSTRACT Background The role of statins in cirrhosis remains controversial. Historically restricted due to safety concerns, emerging evidence highlights potential pleiotropic benefits, though effects on mortality and
Bernardo de Faria Moraes, Gustavo André Pedral Diniz Leite, Igor Boechat Silveira, Gabriel André Pedral Diniz Leite, Maria Luisa Motta Fonseca, Leonardo Corrêa Suffert, Luisa Medeiros Visentini, Luis Pedro Possapp Beis, Guilherme Grossi Lopes Cançado   +8 more
wiley   +1 more source